Skip to main content

Pragmatech AI Solutions

Category: AI in Healthcare

An AI-powered clinical decision support platform that predicts optimal antibiotic treatments for infectious diseases in real-time, eliminating the 48-hour wait for laboratory culture results. Pragmatech AI Solutions was founded in 2021. The company is led by Javier Fernández Domínguez. Based in Oviedo, Spain. Team size: 5-10. Total funding raised: €650k. Latest round: Seed. Key investors include First Drop, Urriellu Ventures.

Founded
2021
Headquarters
Oviedo, Spain
Team size
5-10
Total funding
€650k

Value proposition

Reduces antibiotic prescribing errors by ~30% and delivers immediate treatment recommendations, bypassing the standard 48-hour wait for lab results.

Products and solutions

iAST® (Intelligent Antibiotic Susceptibility Testing), iLynx® (AI-driven Pharmacovigilance & Trend Monitoring)

Unique value

Replaces 'wait-and-see' empirical prescribing with data-driven predictive precision medicine using only software.

Target customer

Public and private hospitals, infectious disease specialists, clinical microbiologists

Industries served

HealthTech, Clinical Microbiology, Infectious Disease Management, Hospital Management

Technology advantage

Proprietary ML models trained on local epidemiological data allow for instant, high-accuracy predictions (92%) with a scalable, hardware-free SaaS delivery model.

How they differentiate

Pure software solution (no hardware costs), instant results (vs 48h), CE Mark certified.

Main competitors

Traditional biological culture methods, Rapid diagnostic hardware providers

Key partnerships

HM Hospitales, First Drop, Urriellu Ventures, Harvard T.H. Chan School of Public Health

Notable customers

HM Hospitales

Major milestones

Founded 2021, CE Mark obtained July 2025, €650k Seed Round Dec 2025

Growth metrics

92% prediction accuracy, 30% reduction in prescribing errors.

Market positioning

Early commercial stage with regulatory advantage in the EU market.

Geographic focus

Spain, Europe

Patents and IP

Proprietary AI algorithms and trade secrets

About Javier Fernández Domínguez

PhD in Clinical Microbiology. Former Researcher at ISPA (Health Research Institute of Asturias) and Specialist in Clinical Microbiology at HUCA.

Official website: